## OXY: Occidental Petroleum Corporation - XLE: Energy

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 5.3% in mid entry zone (3.0-6.0%), top 5% cross-sectional ranking. Short-term MRS_5 (3.9%) confirms momentum alignment. Strong momentum (+7.2% 5-day acceleration). Outperforming sector by 2.8%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($40.48)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 6, Bearish: 0)

**1. Unusual Activity in Occidental Petroleum Call Options - A Signal Investors Expect a Dividend Hike**
- Source: FinancialContent | 20251231T133000 | Bullish | Relevance: 100%
- Investors are showing strong interest in Occidental Petroleum (OXY) call options expiring in January 2026, driven by expectations of a dividend hike. High trading volume in specific call options suggests that investors believe OXY's stock price will increase significantly, possibly reaching a target of $50 per share if the dividend yield normalizes. The article also discusses a "safer" alternative strategy involving shorting out-of-the-money put options to finance calls, thereby mitigating some risk.

**2. Occidental sells chemical business to Berkshire Hathaway for $9.7 billion**
- Source: Investing.com | 20260102T150824 | Bullish | Relevance: 100%
- Occidental Petroleum (NYSE:OXY) has completed the sale of its chemical business, OxyChem, to Berkshire Hathaway (NYSE:BRK.A, BRK.B) for $9.7 billion in cash. This divestiture, representing approximately 24% of Occidentalâ€™s market capitalization, is aimed at strengthening its balance sheet and focusing on its core oil and gas operations. The company expects this cash infusion to significantly improve its financial position, which currently includes $22.88 billion in total debt.

**3. Occidental Completes Sale of OxyChem**
- Source: Stock Titan | 20260102T144656 | Neutral | Relevance: 100%
- Occidental (NYSE: OXY) has completed the sale of its chemical business, OxyChem, to Berkshire Hathaway for $9.7 billion in cash. This transaction aims to strengthen Occidental's balance sheet and allow it to focus on its oil and gas portfolio. Occidental will retain legacy environmental liabilities and expects long-term remediation spending.

**4. Ascent Group LLC Has $1.50 Million Position in Occidental Petroleum Corporation $OXY**
- Source: MarketBeat | 20260102T085025 | Somewhat-Bullish | Relevance: 100%
- Ascent Group LLC increased its stake in Occidental Petroleum Corporation (NYSE:OXY) by 492.2% in the third quarter, bringing their total holdings to $1.499 million. Many other institutional investors also adjusted their positions, and a director recently acquired 5,000 shares of the stock. Analysts currently rate Occidental Petroleum as a "Hold" with an average target price of $49.95.

**5. Unusual activity in Occidental Petroleum call options - a signal investors expect a dividend hike**
- Source: MSN | 20260101T000846 | Bullish | Relevance: 100%
- Unusual call option activity for Occidental Petroleum (OXY) suggests investors anticipate a dividend increase rather than just a stock price appreciation. This large call purchase for the July 2024 $70 strike price could indicate expectations for OXY to significantly raise its dividend, potentially driven by strong free cash flow and a commitment to shareholder returns.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 3)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | UBS | $43 | $45 | -4% |
| 2025-12-11 | B of A Securiti | $44 | $45 | -2% |
| 2025-12-08 | JP Morgan | $44 | $51 | -14% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | UBS | main | Neutral |
| 2025-12-11 | B of A Securiti | main | Neutral |
| 2025-12-08 | JP Morgan | down | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 1 ($0.19M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 59.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 3 |

**Top Holders:**
- Berkshire Hathaway, : 26.9% (0.0%)
- Vanguard Group Inc: 9.1% (+0.8%)
- Dodge & Cox Inc.: 8.1% (-0.5%)
- Blackrock Inc.: 5.0% (+3.4%)
- State Street Corpora: 3.9% (-0.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_10 improving +7.2% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.38 elevated, pricing in significant growth expectations. Balance sheet: $1.0B free cash flow. Revenue declining -18% YoY, concerning. Analyst sentiment negative (3 target cuts vs 0 raises). Institutional flow bullish (5 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $41.8B |
| Beta | 0.39 |
| 52W Range | $34.78 - $53.20 |
| Short Interest | 5.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.38 |
| Forward P/E | 26.9 |
| Current P/E | 18.8 |
| YoY Growth | -30.1% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -1.9% to 5.3% (+7.2% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (3.0-6.0%), cross-sectional ranking at 94th percentile. MRS_5 at 3.9% confirms short-term momentum alignment. Below SMA200 (0.98x), long-term trend not supportive. RSI neutral at 59. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 5.33% (CS: 95) | Strong |
| RSI_14 | 59.0 | Neutral |
| MACD Histogram | 0.23 | Bullish |
| vs SMA20 | 1.038x | Above |
| vs SMA50 | 1.027x | Above |
| vs SMA200 | 0.982x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $42.38
- **Stop Loss:** $40.48 (4.5% risk)
- **Target:** $45.23 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 757
- **Position Value:** $32,081.66
- **Portfolio %:** 32.08%
- **Risk Dollars:** $1,440.00
- **Risk Per Trade:** 1.44%
- **Modifiers:** L1 120% | L2 120% | Combined 1.44x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-02-17 (Est: $0.38)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.50 | $0.64 | +26.8% |
| 2025Q2 | $0.31 | $0.39 | +24.8% |
| 2025Q1 | $0.76 | $0.87 | +14.0% |
| 2024Q4 | $0.67 | $0.80 | +19.4% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_10*